Canadian Rheumatology Association (CRA) and Allied Health Professions Association (AHPA) Interview Series 2015
Today’s feature interview – Dr. Mary-Anne Fitzcharles: The 101 on Joints for Joints
ABN reporters from Canada’s arthritis consumer organizations interviewed leading health professionals and researchers during last month’s CRA and AHPA annual meetings.
Beginning March 9, feature interviews will be posted on the ABN YouTube channel http://bit.ly/ABNYouTube. Please help us raise awareness about the important work going on in Canada by sharing the interviews with your organizational and social networks.
About Dr. Mary-Anne Fitzcharles
Dr. Fitzcharles is currently an associate professor of medicine in the Division of Rheumatology at McGill University. She completed her training in rheumatology at The London Hospital, Whitechapel, London, England. She received her medical education at the University of Cape Town, South Africa. She has been on the faculty at McGill University since 1984, and is a consultant rheumatologist at the McGill Pain Centre. Her past accomplishments include being an examiner for the Royal College of Physicians of Canada Internal Medicine Specialist Examinations for 15 years, a member of Medical Admissions committee for medical students to McGill University for 15 years, and director of postgraduate medical education at Royal Victoria Hospital, and member of postgraduate medical education board of McGill University. In the past 10 years, research interests have been in the area of pain management and alternative treatments use in rheumatic diseases, with a focus on rheumatoid arthritis and osteoarthritis.
About medicinal cannabis
Medical cannabis refers to the use of plant material, either whole or in extra form. Medical cannabis contains various cannabinoid molecules such as tetrahydrocannabinol (THC) and cannabidiol (CBD). THC has pain relieving and psychoactive (mind altering) properties. CBD is believed to reduce pain and inflammation without having psychoactive side effects.